Potential protective effects of l-carnitine against neuromuscular ischemia-reperfusion injury: From experimental data to potential clinical applications

Clinical Nutrition

Volumn 35, Issue 4, 2016, Pages 783-790

  Moghaddas, Azadeh ^a   Dashti Khavidaki, Simin ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anti inflammatory; Antioxidant; Ischemia reperfusion injury; L carnitine

Indexed keywords

ACETYLCYSTEINE; ADENOSINE; ALPHA TOCOPHEROL; ASCORBIC ACID; AZATHIOPRINE; CARNITINE; CARNITINE DERIVATIVE; GLYCINE PROPIONYLCARNITINE; LEVACECARNINE; PROPIONYLCARNITINE; TACROLIMUS; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN LEVEL; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL (TOPIC); CONTINUOUS INFUSION; DRUG DOSE INCREASE; DRUG MECHANISM; HUMAN; ISCHEMIA; MUSCLE INJURY; NERVE CELL; NEUROMUSCULAR SYSTEM; NEUROPROTECTION; NONHUMAN; REPERFUSION INJURY; REVIEW; SKELETAL MUSCLE; SPINAL CORD INJURY; SYSTEMATIC REVIEW; TISSUE DISTRIBUTION; ANIMAL; DISEASE MODEL; DRUG EFFECTS; PATHOLOGY;

ANIMALS; CARNITINE; CENTRAL NERVOUS SYSTEM; DISEASE MODELS, ANIMAL; HUMANS; MUSCLE, SKELETAL; REPERFUSION INJURY;

EID: 84937127979     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2015.07.001     Document Type: Review

References (78)

1. Petrishchev N.N., Vlasov T.D. Endothelium functions in ischemia reperfusion (a literature review). Ross FiziolZhIm Im Sechenova 2000, 86:148-163.
2. Tapuria N., Kumar Y., Habib M.M., Abu Amara M., Seifalian A.M., Davidson B.R. Remote ischemic preconditioning: a novel protective method from ischemia reperfusioninjury-a review. J Surg Res 2008, 150:304-330.
3. Zanelli S.A., Solenski N.J., Rosenthal R.E., Fiskum G. Mechanisms of ischemic neuroprotectionby acetyl-L-carnitine. Ann N. Y Acad Sci 2005, 1053:153-161.
4. Stephens F.B., Constantin-Teodosiu D., Greenhaff P.L. New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscle. J Physiol 2007, 581:431-444.
5. Kristian T., Siesjo B.K. Calcium in ischemic cell death. Stroke 1998, 29:705-718.
6. Erecinska M., Silver I.A. Ions and energy in mammalian brain. Prog Neurobiol 1994, 43:37-71.
7. Hansenc A.J. Effect of anoxia on ion distribution in the brain. Physiol Rev 1985, 65:101-148.
8. Bambrick L., Kristian T., Fiskum G. Astrocyte mitochondrial mechanisms of ischemic brain injury and neuroprotection. Neurochem Res 2004, 29:601-608.
9. Sanderson T.H., Reynolds C.A., Kumar R., Przyklenk K., Hüttemann M. Molecular mechanisms of ischemia-reperfusion injury in brain. Pivotal role of the mitochondrial membrane potential in reactive oxygen specious generation. Mol Neurobiol 2013, 47:9-23.
10. Trotti D, Rossi D, Gjesdal O, Levy LM, Racagni G, Danholt NC, et al. Peroxynitrite inhibits glutamate transporter subtypes. J Biol Chem1996; 271: 5976-5979.
11. van den Heuvel M.G.W., Buurman W.A., Bast A., van der Hulst R.R.W.J. Review: ischemia-reperfusion injury in flap surgery. J Plast Reconstr Aesthet Surg 2009, 62:721-726.
12. Dux E., Mies G., Hossmann K.A., Siklos L. Calcium in the mitochondria following brief ischemia of gerbil brain. Neurosci Lett 1987, 78:295-300.
13. Zaidan E., Sims N.R. The calcium content of mitochondria from brain subregions following short-term forebrain ischemia and recirculation in the rat. J Neurochem 1994, 63:1812-1819.
14. Kalogeris T., Baines C.P., Krenz M., Korthuis R.J. Cell biology of ischemia/reperfusion injury. Int Rev Cell Mol Biol 2012, 298:229-317.
15. Bullock R., Fujisawa H. The role of glutamate antagonists for the treatment of CNS injury. J Neurotrauma 1992, 2:443-462.
16. Morciano G., Giorgi C., Bonora M., Punzetti S., Parasini R., Wieckowski M.R., et al. Molecular identity of mitochondrial permeability transition pore and its role in ischemia reperfusion injury. J Mol Cell Cardiol 2015, 78:142-153.
17. Naderi J., Hung M., Pandey S. Oxidative stress induced apoptosis in dividing fibroblasts involves activation of p38 MAP kinase and over-expression of bax: resistance of quiescent cells to oxidative stress. Apoptosis 2003, 8:91-100.
18. Zoratti M., Szabo I. The mitochondrial permeability transition. Biochim Biophys Acta 1995, 1241:139-176.
19. Perrelli M.G., Pagliaro P., Penna C. Ischemia/reperfusion injury and cardioprotective mechanisms: role of mitochondria and reactive oxygen species. World J Cardiol 2011, 3:186-200.
20. Bremer J. Carnitine metabolism and functions. Physiol Rev 1983, 63:1420-1480.
21. Bieber L.L. Carnitine Annu Rev Biochem 1988, 57:261-283.
22. Zammit V.A., Ramsay R.R., Bonomini M., Arduini A. Carnitine, mitochondrial function and therapy. Adv Drug Deliv Rev 2009, 61:1353-1362.
23. Jones L.L., McDonald D., Borum P.R. Acylcarnitines: role in brain. Prog Lipid Res 2010, 49:61-75.
24. Malaguarnera M. Carnitine derivatives: clinical usefulness. Curr Opin Gastroenterol 2012, 28:166-176.
25. Mayes PA. Lipids of physiologic significance. In: Murray RK, Granner DK, Mayes PA, Rodwell VW (Eds), Harper's biochemistry. 25th edn. Appleton and Lange, Stanford, pp. 160-171.
26. Kristián T. Metabolic stages, mitochondria and calcium in hypoxic/ischemic brain damage. Cell Calcium 2004, 36:221-233.
27. Gülҫin I˙ Antioxidant and antiradical activities of L-carnitine. Life Sci 2006, 78:803-811.
28. Shug A.L., Schmidt M.J., Golden G.T., Fariello R.T. The distribution and role of carnitine in the mammalian brain. Life Sci 1982, 31:2869-2874.
29. Mroczkowska J.E., Gala H.J., Nalecz M.J., Nalecz K.A. Evidence for an asymmetrical uptake of L-carnitine in the blood-brain in vitro. Biochem Biophys Res Commun 1997, 241:127-131.
30. Kido Y., Tamai I., Ohnari A., Sai Y., Kagami T., Nezu J., et al. Functional relevance of carnitine transporter OCTN2 to brain distribution of L-carnitine and acetyl-L-carnitine across the blood-brain barrier. J Neurochem 2001, 79:959-969.
31. Virmani M.A., Conti R., Rossi S.S., Arrigoni-Martelli E. L-carnitine uptake into primary rat cortical culture: interaction with GABA. Brain Res Mol Brain Res 1994, 25:105-112.
32. Binienda Z.K., Ali S.F. Neuroprotective role of L-carnitine in the 3-nitropropionic acid induced neurotoxicity. Toxicol Lett 2001, 125:67-73.
33. Ando S., Tadenuma T., Tanaka Y., Fukui F., Kobayashi S., Ohashi Y., et al. Enhancement of learning capacity and cholinergic synaptic function by carnitine in aging rats. J Neurosci Res 2001, 66:266-271.
34. Pettegrew J.W., Levine J., McClure R.J. Acetyl L-carnitine physical-chemical, metabolic and therapeutic properties: relevance for its mode of action in alzheimer's disease and geriatric depression. Mol Psych 2000, 5:616-632.
35. Calvani M., Arrigoni-Mortelli E. Attenuation by acetyl-L-carnitine of neurological damage and biochemical derangement following brain ischemia and reperfusion. Int J Tissue React 1999, 21:1-6.
36. Fiskum G, Murphy AN, Beal MF. Mitochondrial in neurodegeneration: acute ischemia and chronic neurodegenerative disease. J Cereb Blood Flow Metab1999;19; 351-369.
37. Chan P.H. Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab 2001, 21:2-14.
38. Rosenthal RE, Williams R, Bogaert YE, Getson PR, Fiskum G. Prevention of postischemic canine neurological injury through potentiation of brain energy metabolism by acetyl-L-carnitine. Stroke1992; 23:1312-1318.
39. Aureli T., Miccheli A., Ricciolini R., Di Cocco M.E., Ramacci M.T., Angelucci L., et al. Aging brain: effect of acetyl-carnitine treatment on the rat brain energy and phospholipid metabolism. A study by 31P and 1H NMR spectroscopy. Brain Res 1990, 526:108-112.
40. Aureli T, Miccheli A, Di Cocco ME, Ghirardi O, Giuliani A, Ramacci MT, et al. Effect of acetyl-L-carnitine on recovery of brain phosphorus metabolites and lactic acid level during reperfusion after cerebral ischemia in the rat- study by 31P and 1H NMR spectroscopy. Brain Res1994; 643: 92-99.
41. Shuaib A., Waqaar T., Wishart T., Kanthan R., Howlett W. Acetyl-L-carnitine attenuates neuronal damage gerbils transient forebrain ischemia only when given before insult. Neurochem Res 1995, 20:1021-1025.
42. Wainwright M.S., Mannix M.K., Brown J., Stumpf D. L-Carnitine reduces brain injury after hypoxia-ischemia in newborn rats. Pediatr 2003, 54:688-695.
43. Onem G, Aral E, Enli Y, Oguz EO, Coskun E, Aybek H, et al. Neuroprotective effects of L-carnitine and vitamin E alone or in combination against ischemia-reperfusion injury in rats. J Surg Res2006; 131:124-130.
44. Wainwright S.M., Kohli R., Whitington P.F., Chace D.H. Carnitine treatment inhibits increases in cerebral carnitine esters and glutamate detected by mass spectrometry after hypoxia-ischemia in newborn rats. Stroke 2006, 37:524-530.
45. Al-Majed A.A., Sayed-Ahmed M.M., Al-Omar F.A., Al-Yahya A.A., Aleisa A.M., Al-Shabanah O.A. Carnitine esters prevent oxidative stress damage and energy depletion following transient forebrain ischemia in the rat hippocampus. Clin Exp Pharmacol Physiol 2006, 33:725-733.
46. Rau T.F. The role of L-carnitine in preventing mitochondrial dysfunction after neonatal hypoxia-ischemia 2007, [Ph.D thesis], University of Montana.
47. Rau T.F., Lu Q., Sharma S., Sun X., Leary G., Beckman M.L., et al. Oxygen glucose deprivation in rat hippocampal slice cultures results in alterations in carnitine homeostasis and mitochondrial dysfunction. PLoS One 2012, 7:40881.
48. Burda1 J., Viadel M.H., Danielisova1 V., Nemethova1 M., Montoliu C., Felipo V. Effect of L-carnitine on postischemic inhibition of protein synthesis in the rat brain. Biophys 2009, 28:242-248.
49. Bareyre F.M., Schwab M.E. Inflammation, degeneration and regenerationin the injured spinal cord: insights from DNA microarrays. Trends Neurosci 2003, 26:555-563.
50. McEwen M.L., Sullivan P.G., Rabchevsky A.G., Springer J.E. Targeting mitochondrial function for the treatment of acute spinal cord injury. Neurotherapeutics 2011, 8:168-179.
51. Hawryluk G.W., Rowland J., Kwon B.K., Fehlings M.G. Protection and repair of the injured spinal cord: a review of completed, ongoing, and planned clinical trials for acute spinal cord injury. Neurosurg Focus 2008, 25. E14.
52. Arduini A, Fernandezi E, Pallini R, Mancinelli G, Di Toppi GS, Belfiglio M, et al. Effect of propionyl-L-carnitine on rat spinal cord ischemia and post-ischemic reperfusion injury. Free Rod Res Commun1990; 10: 325-332.
53. Rahman A., Stuendagb B.U., Burma O., Ozercan I.H., Erol F.S. Neuroprotective effect of regional carnitine on spinal cord ischemia/reperfusion injury. Eur J Cardiothorac Surg 2001, 20:65-70.
54. Tetik O., Yagdi T., Islamoglu F., Calkavur T., Posacioglu H., Atay Y., et al. The effects of L-carnitine on spinal cord ischemic/reperfusion in rabbits. Torac Cardiov Surg 2002, 5:11-15.
55. Dargin O.T., Bakhroglu L., Ozkul Y., Ozardali I. Prevention of postischernic spinal cord injury by means of regional infusion of adenosine and L-carnitine dissolved in norrnotherrnic saline. Ann Vasc Surg 2004, 18:343-348.
56. Akgun S., Tekeli A., Kurtkaya O., Civelek A., Isbir S.C., Ak K., et al. Neuroprotective effects of FK-506, L-carnitine and azathioprine on spinal cord ischemia-reperfusion injury. Eur J Cardiothorac Surg 2004, 25:105-110.
57. Patel S.P., Sulivan P.G., Lyttle T.S., Ravcheski A.V. Acetyl-L-carnitine ameliorates mitochondrial dysfunction following contusion spinal cord injury. J Neurochem 2010, 114:291-301.
58. Karaljia A., Novikova L.N., Kinghman P.J., Wiberg M., Novikov L.N. Neuroprotective effects of N-acetyl-cysteine and acetyl-L-carnitine after spinal cord injury in adult rats. Plos One 2012, 1086:7.
59. Lolic M.M., Fiskum G., Rosenthal R.E. Neuroprotective effects of acetyl-L-carnitine after stroke in rats. Ann Emerg Med 1997, 29:758-765.
60. Bogaert Y.E., Rosenthal R.E., Fiskum G. Postischemic inhibition of cerebral cortex pyruvate dehydrogenase. Free Rad Biol Med 1994, 16:811-820.
61. Dringen R., Gebhardt R., Hamprecht B. Glycogen in astrocytes: possible function as lactate supply for neighboring cells. Brain Res 1993, 623:208-214.
62. Furlong J.H. Acetyl-L-carnitine: metabolism and applications in clinical practice. Altern Med Rev 1996, 1:85-93.
63. Foreman P.J., Perez-Polo J.R., Angelucci L., Ramacci M.T., Taglialatela G. Effects of acetyl-L-carnitine treatment and stress exposure on the nerve growth factor receptor [p75NGFR] mRNA level in the central nervous system of aged rats. Prog Neuropsycho Pharmacol Biol Psychiat 1995, 19:117-133.
64. Sima A.A.F., Ristic H., Merry A., Kamijo M., Lattimer S.A., Stevens M.J., et al. Primary preventive and secondary interventionary effects of acetyl-L-carnitine on diabetic neuropathy in the bio-breeding worcester rat. J Clin Invest 1996, 97:1900-1907.
65. Abdul H.M., Butterfield D.A. Involvement of PI3K/PKG/ERK1/2 signaling pathways in cortical neurons to trigger protection by cotreatment of acetyl-L-carnitine and alpha-lipoic acid against HNE-mediated oxidative stress and neurotoxicity: implications for alzheimer's disease. Free Radic Biol Med 2007, 42:371-384.
66. Winter B.K., Fiskum G., Gallo L.L. Effects of L-carnitine on serum triglyceride and cytokine levels in rat models of cachexia and septic shock. Br J Cancer 1995, 72:1173-1179.
67. Blaisdell W. The pathophysiology of skeletal muscle ischemia and the reperfusion syndrome: a review. Cardiovasc Surg 2002, 10:620-630.
68. Adembri C., Domenici L.L., Formigli L., Brunelleschi S., Ferrari E., Novelli G.P. Ischemia-reperfusion of human skeletal muscle during aortoiliac surgery: effects of acetylcarnitine. Histol Histopathol 1994, 9:683-690.
69. Brevetti G., Perna S., Sabbá C., Martone V.D., Condorelli M. Propionyl-L-carnitine in intermittent claudication: double-blind, placebo-controlled, dose titration, multicenter study. J Am Cell Cardiol 1995, 26:1411-1416.
70. Akar H., Sarac A., Konuralp C., Yildizc L., Kolbakir F. Comparison of histopathologic effects of carnitine and ascorbic acid on reperfusion injury. Eur J Cardiothorac Surg 2001, 19:500-506.
71. Andreozzi G.M., Martini R., Cordova R.M., D'Eri A. L-propionylcarnitine protects tissue from ischemic injury in an in vivo human ischemia-reperfusion model. Clin Drug Investig 2002, 22:15-21.
72. Bloomer R.J., Tschume L.C., Smith W.A. Glycine propionyl-L-carnitine modul lipid peroxidation nitric oxide hum subjects. Int J Vitam Nutr Res 2009, 79:131-141.
73. Bloomer R.J., Smith W.A., Fisher-Wellman K.H. Oxidative stress in response to forearm ischemia-reperfusion with and without carnitine administration. Int J Vitam Nutr Res 2010, 80:12-23.
74. Demirel M., Kaya B., Cerkez C., Ertunc M., Sara Y. L-Carnitine pretreatment protects slow-twitch skeletal muscles in a rat model of ischemia-reperfusion injury. Vac Endovasc Surg 2013, 47:540-545.
75. Andreozzi G.M., Leone A., Laudani R., Martin R., Deinit G., Cataldi V. Levopropionyl carnitine improves the effectiveness of supervised physical training onthe absolute claudicationdistance in patients with intermittent claudication. Angiology 2008, 59:84-89.
76. Dutta A., Ray K., Singh V.K., Vats P., Singh S.N., Singh S.B. L-carnitine supplementation attenuates intermittent hypoxia-induced oxidative stress and delays muscle fatigue in rats. Exp Physiol 2008, 93:1139-1146.
77. Scarabelli T.M., Gottlieb R.A. Functional and clinical repercussions of myocyte apoptosis in the multifaceted damage by ischemia/reperfusion injury: old and new concepts after 10 years of contributions. Cell Death Differ 2004, 11:44-52.
78. Khanna A., Cowled P.A., Fitridge R.A. Nitric oxide and skeletal muscle reperfusion injury: current controversies (research review). J Surg Res 2005, 128:98-107.